OEM News

SandboxAQ and Mayo Clinic Collaborate on Novel Cardiac Diagnostics

Clinical research study validates the efficacy of advanced AI-powered magnetocardiography for cardiac diagnostics.

Author Image

By: Rachel Klemovitch

Assistant Editor

SandboxAQ has entered a technology collaboration with Mayo Clinic to explore the use of advanced, AI-powered magnetocardiography (MCG) technology. The collaboration aims to radically improve cardiac diagnostics and marks a significant step forward in the global fight against cardiovascular diseases.
 
“This collaboration between Mayo Clinic and SandboxAQ will further this breakthrough MCG technology for cardiac diagnostics. Cardiac disease is the leading cause of death globally and novel methods to easily and accurately diagnose disease are urgently needed,” said Kit Yee Au-Yeung, Director of SandboxAQ’s medical devices division. “CardiAQ captures detailed data from the heart, which could lead to faster, more accurate diagnoses and fill in the gap between low-cost EKG or biomarker tests and high-cost CT scans or invasive angiography.”
 
Mayo Clinic researchers will test SandboxAQ’s novel MCG imaging system, CardiAQ, powered by state-of-the-art magnetic sensors and advanced AI algorithms. This is a mobile, non-invasive, non-contact cardiac imaging device that will enable rapid and radiation-free visualization and assessment of the magnetic signals of the heart. 
 
The initial phase of the collaboration will be a clinical research study to examine the relationship between MCG and the findings seen in angiography. The study will take place throughout 2024 and 2025 at the Mayo Clinic in Rochester, MN.
 
CardiAQ will address the need for faster, more accurate, and accessible medical imaging technologies. The system uses high-performance sensors to measure minute variations in the magnetic field around the human heart, and advanced quantitative AI algorithms that can eliminate electromagnetic interference in a hospital environment. 
 
By capturing more pristine electrical conduction activities in every heartbeat, doctors may be able to better detect abnormal patterns and uncover other indicators about potential cardiac disease states.
 
The CardiAQ requires no purpose-built space, needs no cooling or shielding to operate, is mobile for point-of-care use, and completes measurements in minutes. These benefits are backed by clinical studies conducted at UCSF Medical Center at New York’s Mount Sinai West medical center. 
 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters